ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05130	Pathogenic Escherichia coli infection	3/12	77/7206	0.000240825671071
ko05100	Bacterial invasion of epithelial cells	3/12	99/7206	0.000505797171437
ko04810	Regulation of actin cytoskeleton	4/12	264/7206	0.000690691572927
ko04014	Ras signaling pathway	4/12	279/7206	0.000850957490425
ko04144	Endocytosis	4/12	342/7206	0.00182147079292
ko04011	MAPK signaling pathway - yeast	2/12	53/7206	0.00334191139961
ko04062	Chemokine signaling pathway	3/12	201/7206	0.003904868132
ko04530	Tight junction	3/12	228/7206	0.00556539426909
ko05200	Pathways in cancer	4/12	492/7206	0.00683496358937
ko05131	Shigellosis	2/12	82/7206	0.00784087153764
ko05212	Pancreatic cancer	2/12	83/7206	0.00802704641053
ko04015	Rap1 signaling pathway	3/12	278/7206	0.00964429581019
ko05132	Salmonella infection	2/12	98/7206	0.0110570142098
ko05410	Hypertrophic cardiomyopathy (HCM)	2/12	100/7206	0.0114940266186
ko04520	Adherens junction	2/12	103/7206	0.0121638168395
ko04122	Sulfur relay system	1/12	8/7206	0.0132512413022
ko04666	Fc gamma R-mediated phagocytosis	2/12	122/7206	0.0167938585953
ko04660	T cell receptor signaling pathway	2/12	124/7206	0.0173192619346
ko04670	Leukocyte transendothelial migration	2/12	151/7206	0.0250863380223
ko04722	Neurotrophin signaling pathway	2/12	160/7206	0.0279432102956
ko04371	Apelin signaling pathway	2/12	177/7206	0.0336843640333
ko00790	Folate biosynthesis	1/12	21/7206	0.0344416188927
ko04932	Non-alcoholic fatty liver disease (NAFLD)	2/12	182/7206	0.0354558520916
ko00515	Mannose type O-glycan biosynthesis	1/12	25/7206	0.0408773117367
ko04072	Phospholipase D signaling pathway	2/12	197/7206	0.0409872002779
ko04921	Oxytocin signaling pathway	2/12	209/7206	0.0456380916506